SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

0
Player Avatar Fiskhus (72.87) Submitted: 3/8/2011 9:41:39 PM : Outperform Start Price: $4.38 SCLN Score: +31.90

MB7 z

Report this Post Reply

Featured Broker Partners


Advertisement